<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intraductal ultrasound for evaluating the pancreaticobiliary ductal system</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intraductal ultrasound for evaluating the pancreaticobiliary ductal system</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Intraductal ultrasound for evaluating the pancreaticobiliary ductal system</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Maurits J Wiersema, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas G Adler, MD, FACG, AGAF, FASGE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Intraductal ultrasound (IDUS) of the pancreaticobiliary ductal system utilizes a small caliber ultrasound catheter (also referred to as a mini-catheter). Because the ultrasound catheter ranges in size from 2 to 3 mm, it can be passed through the accessory channel of a duodenoscope and into the pancreatic or bile duct. The ultrasound catheter's small caliber, wire-guided design, flexibility, and high resolution imaging facilitate the evaluation of biliary, pancreatic, and ampullary disorders  (<a class="graphic graphic_table graphicRef74332" href="/z/d/graphic/74332.html" rel="external">table 1</a>).</p><p>This topic will discuss the imaging principles, procedure technique, and clinical applications of IDUS. We generally use IDUS to complement endoscopic and radiographic imaging during endoscopic retrograde cholangiopancreatography (ERCP), which has evolved into mostly a therapeutic procedure. An overview of ERCP is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"</a>.)</p><p>The role of small caliber ultrasound catheters for evaluating other parts of the gastrointestinal tract is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2679.html" rel="external">"Endoscopic ultrasound (EUS): Use of miniprobes for evaluating gastrointestinal lesions"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PROCEDURE</span></p><p class="headingAnchor" id="H1612704623"><span class="h2">Patient preparation</span><span class="headingEndMark"> — </span>The preprocedure preparation for patients undergoing IDUS is similar to the preparation for patients undergoing ERCP, and these issues are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Patient preparation'</a>.)</p><p class="headingAnchor" id="H2180229027"><span class="h2">Imaging principles</span><span class="headingEndMark"> — </span>IDUS produces higher resolution images than standard endoscopic ultrasound (EUS) [<a href="#rid1">1</a>]. Close proximity of the ultrasound transducer to the duct wall permits the use of high frequency, high resolution sound waves. The pancreatic and bile ducts have a tubular anatomy, are fluid filled, and are only slightly larger in caliber than the IDUS catheter. In addition, the IDUS catheter operates at higher frequencies (12 to 20 MHz) than standard EUS imaging [<a href="#rid1">1,2</a>]. The use of high frequencies produces high resolution images and detailed examination of ductal and periductal tissues. However, the limited depth of penetration prevents detailed examination of the surrounding tissue and more distant sites.</p><p class="headingAnchor" id="H378370364"><span class="h2">Equipment</span><span class="headingEndMark"> — </span>Commercially-available systems for performing IDUS are listed in the table  (<a class="graphic graphic_table graphicRef70245" href="/z/d/graphic/70245.html" rel="external">table 2</a>). </p><p>Mechanical ultrasound catheters include the following components: </p><p class="bulletIndent1"><span class="glyph">●</span>A single transducer mounted on the tip of a wire that allows the transducer to rotate and produce a 360-degree image</p><p class="bulletIndent1"><span class="glyph">●</span>A cable that excites the transducer and transfers signals to the image processor </p><p class="bulletIndent1"><span class="glyph">●</span>A flexible protective housing</p><p></p><p>Some ultrasound catheters provide biplane imaging by allowing the transducer to move in both radial and linear planes. </p><p>Design variations exist for IDUS systems, and some systems incorporate the use of a guidewire  (<a class="graphic graphic_picture graphicRef79640" href="/z/d/graphic/79640.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef69099" href="/z/d/graphic/69099.html" rel="external">picture 2</a>). Mechanical catheters with a guidewire port permit mechanical rotating sector scanning and linear scanning with three-dimensional reconstruction.</p><p class="headingAnchor" id="H4281886901"><span class="h2">Technique</span></p><p class="headingAnchor" id="H3255461808"><span class="h3">Evaluating the biliary tract</span><span class="headingEndMark"> — </span>The procedural technique for IDUS in the biliary tract is summarized as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Accessing the bile duct</strong> – We typically perform IDUS by inserting the ultrasound catheter through the ampulla of Vater during endoscopic retrograde cholangiopancreatography (ERCP), but IDUS can also be performed using a percutaneous approach. The small caliber of the wire-guided ultrasound catheter (ie, 2 to 3 mm in diameter) facilitates cannulating an intact biliary sphincter [<a href="#rid3">3-5</a>]. If endoscopic sphincterotomy is planned for patients with biliary obstruction, we perform IDUS prior to sphincterotomy to help retain fluid and minimize insufflation of the biliary tree. An intact biliary sphincter optimizes acoustic coupling and image quality. Patients with tight biliary strictures may require balloon or catheter dilation to facilitate inserting the ultrasound catheter. However, we target a post-dilation diameter that will allow catheter insertion but avoid excessive tissue disruption because it may impact bile duct wall thickness and overall appearance. </p><p></p><p class="bulletIndent1">The total time for performing IDUS, including catheter insertion and imaging time, is approximately 5 to 10 minutes [<a href="#rid1">1,6</a>]. This does not include time required to perform ERCP. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging technique</strong> – All IDUS catheters are mechanical. We usually perform IDUS using a pullback imaging technique. We maintain the elevator of the duodenoscope in the down (relaxed) position while the catheter is being withdrawn. In our experience, this minimal elevator technique reduces tension on the rotating cable of the catheter and extends the lifespan of the catheter. In some settings, using a stiffer guidewire (ie, 0.035 inches in diameter) may facilitate this technique. As an example, we use a stiffer guidewire to help advance the catheter in patients with proximal biliary strictures. (See  <a class="medical medical_review" href="/z/d/html/640.html" rel="external">"Endoscopic biliary sphincterotomy", section on 'Guidewires'</a>.) </p><p></p><p class="bulletIndent1">IDUS produces high quality imaging of the biliary system and surrounding structures, such as the right hepatic artery, portal vein, and the hepatoduodenal ligament  (<a class="graphic graphic_diagnosticimage graphicRef61520" href="/z/d/graphic/61520.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef74347" href="/z/d/graphic/74347.html" rel="external">image 2</a>). Examination of more distant tissues is hindered by its limited depth of penetration [<a href="#rid7">7-10</a>]. IDUS may also have limited value in evaluating lymph nodes, and unlike EUS, IDUS provides diagnostic assessment only and cannot be used to perform fine needle aspiration. (See  <a class="medical medical_review" href="/z/d/html/2656.html" rel="external">"Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging appearance</strong> – The normal bile duct appears as either two or three layers, which is similar to that seen during EUS [<a href="#rid2">2,11,12</a>]. The normal bile duct wall is 0.31 to 0.79 mm thick, with smooth inner and outer surfaces and homogeneous internal echoes [<a href="#rid13">13</a>]. When visualized as a two-layer structure, an internal hypoechoic layer is seen, which represents the mucosa, muscularis propria (fibromuscular layer), and fibrous layer of the subserosa [<a href="#rid14">14,15</a>]. An outer hyperechoic layer represents the adipose layer of the subserosa, the serosa, and the interface echo between the serosa and surrounding organs. A third inner hyperechoic layer, representing an interface, will occasionally be identified. It may not be possible to differentiate the fibromuscular layer from the perimuscular connective tissue in some patients in whom they appear as a single hypoechoic layer. </p><p></p><p class="headingAnchor" id="H4088942914"><span class="h3">Evaluating the pancreatic ducts</span><span class="headingEndMark"> — </span>The technique for performing IDUS of the pancreatic duct is similar to the technique for examination of the bile duct (see <a class="local">'Evaluating the biliary tract'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Accessing the pancreatic duct</strong> – We typically perform IDUS by inserting the ultrasound catheter into the pancreatic duct, although the proximal portion of the pancreatic duct may be tortuous [<a href="#rid6">6,16</a>]. However, cannulating the pancreatic duct does not typically require pancreatic sphincterotomy. In a study including 153 patients who underwent ERCP, the IDUS catheter was successfully passed into the pancreatic head, body, and tail in 94, 89, and 55 percent of patients, respectively [<a href="#rid6">6</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging appearance</strong> – The ultrasound appearance of the wall of the main pancreatic duct varies from a single hyperechoic layer to three layers. When three layers are present, the inner and outer layers are hyperechoic, with an intervening hypoechoic layer [<a href="#rid12">12</a>].</p><p></p><p class="headingAnchor" id="H3036524897"><span class="h2">Adverse events</span><span class="headingEndMark"> — </span>Adverse events attributed to IDUS are uncommon but may include pancreatitis and catheter fracture [<a href="#rid3">3,6,17-19</a>]. However, most studies do not typically distinguish adverse events related specifically to IDUS from events due to the ERCP itself. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Adverse events'</a>.)</p><p>Limited data suggested that performing IDUS during ERCP was not associated with increased risk of post-ERCP pancreatitis. In two studies including 443 patients who underwent IDUS, four patients (0.9 percent) developed mild pancreatitis [<a href="#rid6">6,16</a>]. The incidence, risk factors, and prevention of post-ERCP pancreatitis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>.)</p><p class="headingAnchor" id="H3962351848"><span class="h2">Post-procedure care</span><span class="headingEndMark"> — </span>After the procedure, patients are recovered from sedation or anesthesia. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Post-procedure care'</a>.)</p><p>The equipment is cleaned per procedural protocol. (See  <a class="medical medical_review" href="/z/d/html/2672.html" rel="external">"Preventing infection transmitted by gastrointestinal endoscopy"</a>.)</p><p class="headingAnchor" id="H665288935"><span class="h1">CONTRAINDICATIONS AND LIMITATIONS</span><span class="headingEndMark"> — </span>Contraindications to IDUS are similar to those for ERCP and include (see  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Contraindications'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who cannot tolerate moderate sedation, monitored anesthesia care, or general anesthesia. (See  <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are hemodynamically unstable.</p><p></p><p>Limitations of IDUS include that it is invasive, uses specialized equipment, requires expertise in advanced endoscopy, increases overall cost, and may not be widely available.</p><p class="headingAnchor" id="H3861988140"><span class="h1">CLINICAL APPLICATIONS</span></p><p class="headingAnchor" id="H3020723265"><span class="h2">Diagnostic role of IDUS</span><span class="headingEndMark"> — </span>IDUS can assist in the evaluation of patients with a variety of pancreaticobiliary disorders  (<a class="graphic graphic_table graphicRef74332" href="/z/d/graphic/74332.html" rel="external">table 1</a>). The most common indications for IDUS of the biliary tract are obstructive jaundice and evaluating indeterminate biliary strictures. IDUS is useful for determining the cause of biliary obstruction and can also assist in local tumor staging.</p><p class="headingAnchor" id="H1296333835"><span class="h2">Biliary disease</span></p><p class="headingAnchor" id="H9"><span class="h3">Bile duct strictures</span><span class="headingEndMark"> — </span>We may use IDUS to evaluate biliary strictures by assessing for the following sonographic features that are suggestive of malignancy  (<a class="graphic graphic_diagnosticimage graphicRef79075" href="/z/d/graphic/79075.html" rel="external">image 3</a>) [<a href="#rid4">4,7,19-25</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>A hypoechoic mass, especially if infiltrating surrounding tissues or &gt;7 mm in thickness</p><p class="bulletIndent1"><span class="glyph">●</span>Heterogeneity of the internal echo</p><p class="bulletIndent1"><span class="glyph">●</span>Notching or irregularity of the outer border</p><p class="bulletIndent1"><span class="glyph">●</span>A papillary surface</p><p class="bulletIndent1"><span class="glyph">●</span>Disruption of the normal bile duct structure</p><p class="bulletIndent1"><span class="glyph">●</span>Suspicious lymph nodes (hypoechoic, round and smooth bordered)</p><p></p><p>Malignant biliary strictures may be related to tumors such as cholangiocarcinoma or pancreatic cancer, and the diagnostic evaluation and staging of these tumors is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">"Clinical manifestations and diagnosis of cholangiocarcinoma"</a> and  <a class="medical medical_review" href="/z/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer"</a>.)</p><p>Biliary strictures that do not have sonographic characteristics of malignancy may be related to a variety of nonmalignant conditions:</p><p class="bulletIndent1"><span class="glyph">●</span>Post-surgical biliary complications (eg, cholecystectomy) (see  <a class="medical medical_review" href="/z/d/html/3681.html" rel="external">"Complications of laparoscopic cholecystectomy"</a> and  <a class="medical medical_review" href="/z/d/html/4589.html" rel="external">"Liver transplantation in adults: Long-term management of transplant recipients", section on 'Biliary complications'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Primary sclerosing cholangitis (see  <a class="medical medical_review" href="/z/d/html/660.html" rel="external">"Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Autoimmune pancreatitis (see  <a class="medical medical_review" href="/z/d/html/5657.html" rel="external">"Autoimmune pancreatitis: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic pancreatitis (see  <a class="medical medical_review" href="/z/d/html/5648.html" rel="external">"Overview of the complications of chronic pancreatitis", section on 'Biliary obstruction'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infectious or ischemic cholangiopathy, including chronic bacterial cholangitis, recurrent pyogenic cholangitis, and biliary parasitosis (see  <a class="medical medical_review" href="/z/d/html/652.html" rel="external">"Recurrent pyogenic cholangitis"</a>)</p><p></p><p>Studies suggested that IDUS demonstrated better overall test performance than other methods for distinguishing malignant from nonmalignant strictures [<a href="#rid4">4,19,20,24,25</a>]. In a study including 234 patients with indeterminate bile duct strictures who underwent endoscopic retrograde cholangiopancreatography (ERCP) with IDUS in addition to endoscopic ultrasound (EUS), computed tomography (CT), and endoscopic transpapillary biopsy, 136 patients (58 percent) had a malignant stricture that was confirmed by surgical histology or median follow-up of 34 months [<a href="#rid24">24</a>]. IDUS had a higher accuracy (ie, ability to correctly differentiate malignant from nonmalignant strictures) compared with EUS, CT, or transpapillary biopsy (91 versus 74, 73, and 59 percent, respectively). For 55 patients who were diagnosed with pancreatic adenocarcinoma, IDUS had higher accuracy compared with EUS or CT (90 versus 81 and 76 percent, respectively) [<a href="#rid24">24</a>]. In another study including 193 patients with indeterminate biliary strictures, 97 patients were diagnosed with malignancy (confirmed by tissue sampling, surgery, and/or long-term follow up) [<a href="#rid19">19</a>]. The sensitivity and specificity of IDUS were 97 and 79 percent, respectively. The accuracy of IDUS (ie, ability to correctly differentiate malignant from nonmalignant strictures) was higher for proximal compared with distal biliary strictures (98 versus 83 percent). Malignant strictures were longer (20 versus 14 mm) and had greater wall thickness (7 versus 3 mm) compared with nonmalignant strictures. </p><p>Other potential applications of IDUS in patients with indeterminate bile duct strictures but negative or nondiagnostic tissue sampling include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surveillance</strong> – IDUS may be useful for surveillance of indeterminate biliary strictures with negative tissue sampling. In a study including 86 patients with indeterminate bile duct strictures who had multiple tests including cholangiography, brush cytology, intraductal biopsy, digital image analysis (DIA), and fluorescence in situ hybridization (FISH), 21 patients (24 percent) with initially negative tissue sampling were later diagnosed with malignant stricture [<a href="#rid25">25</a>]. IDUS had higher sensitivity for diagnosing malignancy compared with combined FISH/DIA, FISH alone, or DIA alone (86 versus 67, 62, and 14 percent, respectively). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Providing US guidance for tissue sampling</strong> – We may use IDUS to target sampling of polypoid or localized bile duct lesions in the setting of an otherwise normal bile duct wall [<a href="#rid26">26</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Identifying possible indications for surgery</strong> – Preliminary studies suggested that some lesion characteristics (eg, a lesion involving and disrupting the bile duct wall) may be an indication for surgical exploration, even in patients with negative tissue sampling [<a href="#rid26">26-28</a>]. Additional studies are needed to confirm these findings before using these IDUS-related lesion characteristics as indications for surgery.</p><p></p><p class="headingAnchor" id="H12"><span class="h3">Primary sclerosing cholangitis</span><span class="headingEndMark"> — </span>For patients with primary sclerosing cholangitis (PSC), we use IDUS to assess biliary strictures for features of malignancy (eg, irregular foci) and facilitate targeted tissue sampling [<a href="#rid22">22,25</a>]. In a study of 40 patients with a PSC-related dominant biliary stricture who underwent ERCP, tissue sampling, and IDUS, eight patients (20 percent) had cholangiocarcinoma [<a href="#rid22">22</a>]. Compared with cholangiography, IDUS had higher sensitivity and specificity for diagnosing malignancy (88 versus 63 percent and 91 versus 53 percent, respectively). However, studies suggested that overall accuracy of IDUS (ie, ability to correctly differentiate malignant from nonmalignant strictures) is lower for PSC-related strictures compared with non-PSC-related strictures (62 versus 82 percent) [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/z/d/html/660.html" rel="external">"Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis", section on 'Dominant biliary strictures'</a> and <a class="local">'Bile duct strictures'</a> above.)</p><p class="headingAnchor" id="H13"><span class="h3">Cholangiocarcinoma</span><span class="headingEndMark"> — </span>IDUS is useful for characterizing malignant bile duct strictures and for local tumor staging of cholangiocarcinoma. IDUS detects early lesions, determines the longitudinal tumor extent, and identifies tumor extension into adjacent organs (eg, pancreas) and major blood vessels (eg, portal vein, hepatic artery) [<a href="#rid8">8,9,29-31</a>]. The use of IDUS for local staging and preoperative planning is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">"Clinical manifestations and diagnosis of cholangiocarcinoma", section on 'Intraductal ultrasound'</a>.)   </p><p>Distinguishing tumor spread from peritumoral bile duct wall inflammation is challenging with IDUS and other noninvasive imaging techniques. Studies suggested that the following factors may facilitate detailed visualization using IDUS [<a href="#rid3">3,19,31-33</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Procedure timing – For patients with malignant biliary obstruction, we perform IDUS ideally prior to or within a few days of biliary stent placement [<a href="#rid3">3,26</a>]. The evaluation of bile duct wall thickening may be impacted by stent-induced inflammation and epithelial hyperplasia that may lead to overestimation of the longitudinal extent of the tumor [<a href="#rid26">26</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thresholds for bile duct thickness – Assessing bile duct wall thickness with IDUS may be helpful in distinguishing inflammatory from malignant conditions. In a study comparing IDUS findings in 23 patients with IgG4-related sclerosing cholangitis (IgG4-SC) with 11 patients with cholangiocarcinoma, bile duct wall thickness &gt;0.8 mm in non-strictured areas on cholangiography was highly suggestive of IgG4-SC, with sensitivity and specificity of 95 and 91 percent, respectively [<a href="#rid31">31,33</a>]. </p><p></p><p class="headingAnchor" id="H3897215287"><span class="h3">Choledocholithiasis</span><span class="headingEndMark"> — </span>The use of IDUS for evaluating patients with suspected choledocholithiasis is generally reserved for those with nondiagnostic imaging (eg, magnetic resonance cholangiopancreatography [MRCP]) and as an option for confirming bile duct clearance following endoscopic stone removal [<a href="#rid18">18,34-39</a>]. The evaluation of suspected choledocholithiasis is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/13922.html" rel="external">"Choledocholithiasis: Clinical manifestations, diagnosis, and management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suspected choledocholithiasis in patients with nondiagnostic studies</strong> – Both larger caliber bile ducts (&gt;10 mm) and smaller stones (&lt;3 mm) reduce the sensitivity of both MRCP and ERCP [<a href="#rid18">18,36,37</a>]. However, IDUS maintains high sensitivity and specificity in both conditions [<a href="#rid18">18,36,37</a>]. In a study including 92 patients with suspected biliary pancreatitis and negative cholangiogram, IDUS demonstrated bile duct stones (mean stone size, 1.9 mm) in 33 patients (36 percent), and the diagnosis was confirmed with endoscopic stone extraction [<a href="#rid37">37</a>]. During mean follow-up of 24 months, two patients (2 percent) had recurrent biliary pancreatitis. However, both patients had stones on IDUS but did not undergo cholecystectomy. In a study including 95 patients with jaundice and suspected choledocholithiasis who had negative cholangiography, bile duct stones were detected by IDUS in 31 patients (33 percent), and stones were confirmed by endoscopic stone removal in all patients [<a href="#rid34">34</a>]. Stone diameter ranged from 1 to 7 mm (mean stone size, 2.9 mm). In addition, IDUS showed biliary sludge in 24 patients (25 percent), which was confirmed by sludge extraction in 21 patients (88 percent). In a study including 32 patients with suspected biliary pancreatitis who had radiologic imaging (transabdominal US, CT, and MRCP) that was followed by ERCP with IDUS, choledocholithiasis was confirmed in 20 patients by stone extraction [<a href="#rid18">18</a>]. The sensitivity of US, CT, MRCP, ERCP and IDUS for identifying choledocholithiasis was 20, 40, 80, 90, and 95 percent, respectively, and specificity was 83, 92, 83, 92, and 92 percent, respectively. Of note, the sensitivity of MRCP decreased with bile duct dilation (bile duct diameter &gt;10 mm, 73 versus 89 percent). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Confirming duct clearance</strong> – Using IDUS to confirm stone clearance has been associated with lower rates of stone recurrence. Although IDUS adds time to ERCP (ie, an additional 5 to 10 minutes), it facilitates achieving complete duct clearance during the index procedure [<a href="#rid38">38,39</a>]. In a study comparing 59 patients who underwent IDUS after ERCP-guided biliary stone removal with 129 patients who had ERCP with stone removal only, rates of stone recurrence after three years were lower in the IDUS group (3 versus 13 percent) [<a href="#rid38">38</a>]. During the index procedure, 14 patients (24 percent) in the IDUS group had residual common bile duct stones (mean stone size, 4.9 mm). In a study of 70 patients with choledocholithiasis based on radiologic imaging (eg, US, MRCP) who underwent ERCP with sphincterotomy and stone extraction followed by IDUS, 28 patients (40 percent) had residual bile duct stones (mean size, 2.2 mm) that were addressed during the index procedure [<a href="#rid39">39</a>]. Although randomized trials are lacking, these data support the use of IDUS for confirming bile duct clearance after endoscopic removal.</p><p></p><p class="headingAnchor" id="H17"><span class="h2">Pancreatic disease</span><span class="headingEndMark"> — </span>Technical advances, test performance, and safety of other methods for pancreatic imaging (eg, CT, magnetic resonance imaging [MRI], EUS) have essentially eliminated the need for ERCP with diagnostic invasive pancreatography. Thus, the role of IDUS of the pancreatic duct is limited to selected patients [<a href="#rid5">5,17,40</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pancreatic cystic neoplasms</strong> – For patients with suspected pancreatic cystic neoplasms  (<a class="graphic graphic_table graphicRef69594" href="/z/d/graphic/69594.html" rel="external">table 3</a>), IDUS has been studied for detecting small lesions, determining the extent of intraductal disease, and assessing for parenchymal invasion. Evaluation with IDUS may help guide surgical planning for patients with mucin-producing tumors involving the main pancreatic duct or for patients with side-branch disease by identifying papillary tumor projections into the main pancreatic duct. </p><p></p><p class="bulletIndent1">However, other imaging studies provide accurate diagnostic and presurgical assessment such that IDUS is not performed in most patients with pancreatic cystic neoplasms. The diagnosis, classification, and management of pancreatic cystic neoplasms is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5637.html" rel="external">"Classification of pancreatic cysts"</a> and  <a class="medical medical_review" href="/z/d/html/5642.html" rel="external">"Pancreatic cystic neoplasms: Clinical manifestations, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1">Data from randomized trials and observation studies suggested that IDUS was useful for surgical planning in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas  (<a class="graphic graphic_picture graphicRef60088" href="/z/d/graphic/60088.html" rel="external">picture 3</a> and <a class="graphic graphic_diagnosticimage graphicRef66688" href="/z/d/graphic/66688.html" rel="external">image 4</a>) [<a href="#rid5">5,17,40,41</a>]. In a trial including 40 patients with IPMN who underwent preoperative testing followed by surgical resection, assessment with IDUS resulted in lower rates of surgical modifications based on intraoperative frozen sections compared with no IDUS (15 versus 50 percent) [<a href="#rid5">5</a>]. Preoperative IDUS also resulted in lower rates of recurrent disease after mean follow-up of 50 months (5 versus 20 percent). In a study including 24 patients with branch duct IPMN who underwent IDUS prior to surgical resection, the sensitivity and specificity of IDUS for detecting lateral tumor spread into the main pancreas duct was 92 and 91 percent, respectively [<a href="#rid40">40</a>]. One false negative occurred in a patient with flat atypia in the main pancreas duct, and one false positive arose in a patient with fibrosis and inflammation in the wall of the main duct.</p><p></p><p class="bulletIndent1">Management of IPMN of the pancreas is discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/16137.html" rel="external">"Intraductal papillary mucinous neoplasm of the pancreas (IPMN): Evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other pancreatic disorders</strong> – IDUS may be used for evaluating indeterminate pancreatic strictures when the diagnosis is uncertain despite advanced imaging and when ERCP is planned for tissue sampling or therapeutic intervention [<a href="#rid16">16</a>]. The diagnostic evaluation of suspected pancreatic cancer is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer"</a>.)</p><p></p><p class="headingAnchor" id="H24"><span class="h2">Ampullary lesions</span><span class="headingEndMark"> — </span>We use IDUS for evaluating the size and extent of ampullary lesions in selected patients (eg, patients with an adenoma in whom the extent of pancreas or biliary ductal infiltration requires clarification prior to endoscopic resection or in whom ampullary carcinoma cannot be excluded). This approach is consistent with society guidelines [<a href="#rid42">42</a>]. However, we do not use IDUS to evaluate all patients with ampullary lesions because of the potential risk of pancreatitis, additional procedure time, and cost. IDUS provides detailed visualization of the papilla and can reliably differentiate the sphincter of Oddi musculature from the papillary orifice [<a href="#rid10">10,42</a>]. </p><p>Studies suggested that accuracy of IDUS for T-staging of ampullary lesions ranged from 87 to 95 percent [<a href="#rid10">10,43</a>]. In a meta-analysis including five studies, the pooled sensitivity and specificity of IDUS for T1 tumors was 90 and 88 percent, respectively; for T2 tumors, 73 and 91 percent, respectively, and for T3 tumors, 79 and 97 percent, respectively [<a href="#rid10">10</a>]. However, the pooled sensitivity for N-staging was 61 percent. In a study including 48 patients with ampullary lesions who underwent surgical or endoscopic resection, IDUS had higher sensitivity for detecting bile duct infiltration compared with EUS (71 versus 43 percent), while both techniques had good specificity (90 versus 98 percent) [<a href="#rid43">43</a>]. </p><p class="headingAnchor" id="H3438773758"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118263.html" rel="external">"Society guideline links: Endoscopic retrograde cholangiopancreatography (ERCP)"</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Background</strong> – Intraductal ultrasound (IDUS) of the pancreaticobiliary system utilizes a small caliber ultrasound catheter that can be passed through the accessory channel of a duodenoscope and into the pancreatic or bile duct. The ultrasound catheter's small caliber, wire-guided design, flexibility, and high resolution imaging are beneficial for evaluating a variety of biliary, pancreatic, and ampullary disorders  (<a class="graphic graphic_table graphicRef74332" href="/z/d/graphic/74332.html" rel="external">table 1</a>). The use of high frequencies allows for detailed examination of ductal and periductal tissues  (<a class="graphic graphic_diagnosticimage graphicRef61520" href="/z/d/graphic/61520.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef74347" href="/z/d/graphic/74347.html" rel="external">image 2</a>). However, the limited depth of penetration prevents examination of more distant sites. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procedure</strong> – IDUS is typically performed by inserting the ultrasound catheter through the ampulla of Vater during endoscopic retrograde cholangiopancreatography (ERCP):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pre- and post-procedure care</strong> – Pre- and post-procedure care is similar to that for patients who undergo ERCP alone. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Patient preparation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Contraindications</strong> – There are few contraindications that are mainly related to ERCP itself, including inability to tolerate anesthesia/sedation and/or hemodynamic instability. (See <a class="local">'Contraindications and limitations'</a> above and  <a class="medical medical_review" href="/z/d/html/2679.html" rel="external">"Endoscopic ultrasound (EUS): Use of miniprobes for evaluating gastrointestinal lesions", section on 'Contraindications'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Adverse events</strong> – Adverse events associated with IDUS are uncommon. Limited data suggested that performing IDUS during ERCP was not associated with increased risk of post-ERCP pancreatitis. (See <a class="local">'Adverse events'</a> above.)</p><p></p><p class="bulletIndent1">Limitations of IDUS include that it is invasive, uses specialized equipment, requires expertise in advanced endoscopy, and may not be widely available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical applications</strong> – Clinical applications of IDUS include (see <a class="local">'Clinical applications'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Indeterminate biliary strictures – IDUS can help differentiate malignant from nonmalignant biliary strictures based on sonographic features such as hypoechoic mass, heterogeneity of the internal echo, and irregularity of the outer border  (<a class="graphic graphic_diagnosticimage graphicRef79075" href="/z/d/graphic/79075.html" rel="external">image 3</a>). (See <a class="local">'Bile duct strictures'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cholangiocarcinoma – IDUS detects early lesions, determines the longitudinal tumor extent, and identifies tumor extension into adjacent organs (eg, pancreas) and major blood vessels (eg, portal vein, hepatic artery). (See <a class="local">'Cholangiocarcinoma'</a> above and  <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">"Clinical manifestations and diagnosis of cholangiocarcinoma", section on 'Intraductal ultrasound'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Suspected but unconfirmed choledocholithiasis – IDUS may be useful for demonstrating choledocholithiasis when other imaging studies (eg, magnetic resonance cholangiopancreatography [MRCP] and/or cholangiography) are nondiagnostic. (See <a class="local">'Choledocholithiasis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pancreatic disease – For patients with intraductal papillary mucinous neoplasm (IPMN), IDUS may distinguish main duct disease from branch duct disease and determine the extent of tumor spread and parenchymal invasion. (See <a class="local">'Pancreatic disease'</a> above.)</p><p></p><p class="headingAnchor" id="H711545622"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Michael J Levy, MD (deceased), who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sun B, Hu B. The role of intraductal ultrasonography in pancreatobiliary diseases. Endosc Ultrasound 2016; 5:291.</a></li><li><a class="nounderline abstract_t">Zhou S, Buxbaum J. Advanced Imaging of the Biliary System and Pancreas. Dig Dis Sci 2022; 67:1599.</a></li><li><a class="nounderline abstract_t">Tamada K, Nagai H, Yasuda Y, et al. Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. Gastrointest Endosc 2001; 53:300.</a></li><li><a class="nounderline abstract_t">Vazquez-Sequeiros E, Baron TH, Clain JE, et al. Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc 2002; 56:372.</a></li><li><a class="nounderline abstract_t">Cheon YK, Cho YD, Jeon SR, et al. Pancreatic resection guided by preoperative intraductal ultrasonography for intraductal papillary mucinous neoplasm. Am J Gastroenterol 2010; 105:1963.</a></li><li><a class="nounderline abstract_t">Menzel J, Domschke W. Intraductal ultrasonography (IDUS) of the pancreato-biliary duct system. Personal experience and review of literature. Eur J Ultrasound 1999; 10:105.</a></li><li><a class="nounderline abstract_t">Tamada K, Ido K, Ueno N, et al. Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995; 27:579.</a></li><li><a class="nounderline abstract_t">Tamada K, Ido K, Ueno N, et al. Assessment of portal vein invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995; 27:573.</a></li><li><a class="nounderline abstract_t">Tamada K, Ueno N, Ichiyama M, et al. Assessment of pancreatic parenchymal invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1996; 28:492.</a></li><li><a class="nounderline abstract_t">Ye X, Wang L, Jin Z. Diagnostic accuracy of endoscopic ultrasound and intraductal ultrasonography for assessment of ampullary tumors: a meta-analysis. Scand J Gastroenterol 2022; 57:1158.</a></li><li><a class="nounderline abstract_t">Fujita N, Noda Y, Kobayashi G, et al. Staging of bile duct carcinoma by EUS and IDUS. Endoscopy 1998; 30 Suppl 1:A132.</a></li><li><a class="nounderline abstract_t">Furukawa T, Naitoh Y, Tsukamoto Y, et al. New technique using intraductal ultrasonography for the diagnosis of diseases of the pancreatobiliary system. J Ultrasound Med 1992; 11:607.</a></li><li><a class="nounderline abstract_t">Kikuchi Y, Tsuyuguchi T, Saisho H. Evaluation of normal bile duct and cholangitis by intraductal ultrasonography. Abdom Imaging 2008; 33:452.</a></li><li><a class="nounderline abstract_t">Fujita N, Noda Y, Kobayashi G. Analysis of the layer structure of the gallbladder wall delineated by endoscopic ultrasound using the pinning method. Dig Endosc 1995; 7:353.</a></li><li><a class="nounderline abstract_t">Noda Y, Fujita N, Kobayashi G, et al. [Comparison of echograms by a microscanner and histological findings of the common bile duct, in vitro study]. Nihon Shokakibyo Gakkai Zasshi 1997; 94:172.</a></li><li><a class="nounderline abstract_t">Furukawa T, Oohashi K, Yamao K, et al. Intraductal ultrasonography of the pancreas: development and clinical potential. Endoscopy 1997; 29:561.</a></li><li><a class="nounderline abstract_t">Hara T, Yamaguchi T, Ishihara T, et al. Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography. Gastroenterology 2002; 122:34.</a></li><li><a class="nounderline abstract_t">Moon JH, Cho YD, Cha SW, et al. The detection of bile duct stones in suspected biliary pancreatitis: comparison of MRCP, ERCP, and intraductal US. Am J Gastroenterol 2005; 100:1051.</a></li><li><a class="nounderline abstract_t">Chen L, Lu Y, Wu JC, et al. Diagnostic Utility of Endoscopic Retrograde Cholangiography/Intraductal Ultrasound (ERC/IDUS) in Distinguishing Malignant from Benign Bile Duct Obstruction. Dig Dis Sci 2016; 61:610.</a></li><li><a class="nounderline abstract_t">Farrell RJ, Agarwal B, Brandwein SL, et al. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures. Gastrointest Endosc 2002; 56:681.</a></li><li><a class="nounderline abstract_t">Domagk D, Wessling J, Reimer P, et al. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am J Gastroenterol 2004; 99:1684.</a></li><li><a class="nounderline abstract_t">Tischendorf JJ, Meier PN, Schneider A, et al. Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2007; 42:1011.</a></li><li><a class="nounderline abstract_t">Tringali A, Lemmers A, Meves V, et al. Intraductal biliopancreatic imaging: European Society of Gastrointestinal Endoscopy (ESGE) technology review. Endoscopy 2015; 47:739.</a></li><li><a class="nounderline abstract_t">Heinzow HS, Kammerer S, Rammes C, et al. Comparative analysis of ERCP, IDUS, EUS and CT in predicting malignant bile duct strictures. World J Gastroenterol 2014; 20:10495.</a></li><li><a class="nounderline abstract_t">Levy MJ, Baron TH, Clayton AC, et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol 2008; 103:1263.</a></li><li><a class="nounderline abstract_t">Tamada K, Tomiyama T, Ichiyama M, et al. Influence of biliary drainage catheter on bile duct wall thickness as measured by intraductal ultrasonography. Gastrointest Endosc 1998; 47:28.</a></li><li><a class="nounderline abstract_t">Tamada K, Ueno N, Tomiyama T, et al. Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy. Gastrointest Endosc 1998; 47:341.</a></li><li><a class="nounderline abstract_t">Gress F, Chen YK, Sherman S, et al. Experience with a catheter-based ultrasound probe in the bile duct and pancreas. Endoscopy 1995; 27:178.</a></li><li><a class="nounderline abstract_t">Kuroiwa M, Tsukamoto Y, Naitoh Y, et al. New technique using intraductal ultrasonography for the diagnosis of bile duct cancer. J Ultrasound Med 1994; 13:189.</a></li><li><a class="nounderline abstract_t">Tamada K, Ido K, Ueno N, et al. Assessment of the course and variations of the hepatic artery in bile duct cancer by intraductal ultrasonography. Gastrointest Endosc 1996; 44:249.</a></li><li><a class="nounderline abstract_t">Choi ER, Chung YH, Lee JK, et al. Preoperative evaluation of the longitudinal extent of borderline resectable hilar cholangiocarcinoma by intraductal ultrasonography. J Gastroenterol Hepatol 2011; 26:1804.</a></li><li><a class="nounderline abstract_t">Kuroiwa M, Goto H, Hirooka Y, et al. Intraductal ultrasonography for the diagnosis of proximal invasion in extrahepatic bile duct cancer. J Gastroenterol Hepatol 1998; 13:715.</a></li><li><a class="nounderline abstract_t">Naitoh I, Nakazawa T, Ohara H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol 2009; 44:1147.</a></li><li><a class="nounderline abstract_t">Kim DC, Moon JH, Choi HJ, et al. Usefulness of intraductal ultrasonography in icteric patients with highly suspected choledocholithiasis showing normal endoscopic retrograde cholangiopancreatography. Dig Dis Sci 2014; 59:1902.</a></li><li><a class="nounderline abstract_t">Fusaroli P, Caletti G. Intraductal ultrasound for high-risk patients: when will the last be first? Dig Dis Sci 2014; 59:1676.</a></li><li><a class="nounderline abstract_t">Endo T, Ito K, Fujita N, et al. Intraductal ultrasonography in the diagnosis of bile duct stones: when and whom? Dig Endosc 2011; 23:173.</a></li><li><a class="nounderline abstract_t">Yoon LY, Moon JH, Choi HJ, et al. Clinical usefulness of intraductal ultrasonography for the management of acute biliary pancreatitis. J Gastroenterol Hepatol 2015; 30:952.</a></li><li><a class="nounderline abstract_t">Tsuchiya S, Tsuyuguchi T, Sakai Y, et al. Clinical utility of intraductal US to decrease early recurrence rate of common bile duct stones after endoscopic papillotomy. J Gastroenterol Hepatol 2008; 23:1590.</a></li><li><a class="nounderline abstract_t">Ang TL, Teo EK, Fock KM, Lyn Tan JY. Are there roles for intraductal US and saline solution irrigation in ensuring complete clearance of common bile duct stones? Gastrointest Endosc 2009; 69:1276.</a></li><li><a class="nounderline abstract_t">Kobayashi G, Fujita N, Noda Y, et al. Lateral spread along the main pancreatic duct in branch-duct intraductal papillary-mucinous neoplasms of the pancreas: usefulness of intraductal ultrasonography for its evaluation. Dig Endosc 2011; 23:62.</a></li><li><a class="nounderline abstract_t">Sho M, Nakajima Y, Kanehiro H, et al. Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas. World J Surg 1998; 22:874.</a></li><li><a class="nounderline abstract_t">Vanbiervliet G, Strijker M, Arvanitakis M, et al. Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021; 53:429.</a></li><li><a class="nounderline abstract_t">Okano N, Igarashi Y, Hara S, et al. Endosonographic preoperative evaluation for tumors of the ampulla of vater using endoscopic ultrasonography and intraductal ultrasonography. Clin Endosc 2014; 47:174.</a></li></ol></div><div id="topicVersionRevision">Topic 2664 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27803901" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The role of intraductal ultrasonography in pancreatobiliary diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35171407" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Advanced Imaging of the Biliary System and Pancreas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11231387" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12196775" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Evaluation of indeterminate bile duct strictures by intraductal US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20407429" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pancreatic resection guided by preoperative intraductal ultrasonography for intraductal papillary mucinous neoplasm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10586015" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Intraductal ultrasonography (IDUS) of the pancreato-biliary duct system. Personal experience and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8608750" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8608749" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Assessment of portal vein invasion by bile duct cancer using intraductal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8886635" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Assessment of pancreatic parenchymal invasion by bile duct cancer using intraductal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35486096" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Diagnostic accuracy of endoscopic ultrasound and intraductal ultrasonography for assessment of ampullary tumors: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9765105" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Staging of bile duct carcinoma by EUS and IDUS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1331496" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : New technique using intraductal ultrasonography for the diagnosis of diseases of the pancreatobiliary system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17639376" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Evaluation of normal bile duct and cholangitis by intraductal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Analysis of the layer structure of the gallbladder wall delineated by endoscopic ultrasound using the pinning method</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9095635" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : [Comparison of echograms by a microscanner and histological findings of the common bile duct, in vitro study].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9342572" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Intraductal ultrasonography of the pancreas: development and clinical potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11781278" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15842578" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The detection of bile duct stones in suspected biliary pancreatitis: comparison of MRCP, ERCP, and intraductal US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26423079" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Diagnostic Utility of Endoscopic Retrograde Cholangiography/Intraductal Ultrasound (ERC/IDUS) in Distinguishing Malignant from Benign Bile Duct Obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12397276" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15330902" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17613933" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26147492" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Intraductal biliopancreatic imaging: European Society of Gastrointestinal Endoscopy (ESGE) technology review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25132767" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Comparative analysis of ERCP, IDUS, EUS and CT in predicting malignant bile duct strictures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18477350" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9468420" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Influence of biliary drainage catheter on bile duct wall thickness as measured by intraductal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9609424" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7601051" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Experience with a catheter-based ultrasound probe in the bile duct and pancreas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7932976" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : New technique using intraductal ultrasonography for the diagnosis of bile duct cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8885342" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Assessment of the course and variations of the hepatic artery in bile duct cancer by intraductal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21649729" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Preoperative evaluation of the longitudinal extent of borderline resectable hilar cholangiocarcinoma by intraductal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9715423" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Intraductal ultrasonography for the diagnosis of proximal invasion in extrahepatic bile duct cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19636664" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25008424" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Usefulness of intraductal ultrasonography in icteric patients with highly suspected choledocholithiasis showing normal endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24894513" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Intraductal ultrasound for high-risk patients: when will the last be first?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21429024" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Intraductal ultrasonography in the diagnosis of bile duct stones: when and whom?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23869951" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Clinical usefulness of intraductal ultrasonography for the management of acute biliary pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18554235" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Clinical utility of intraductal US to decrease early recurrence rate of common bile duct stones after endoscopic papillotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19249039" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Are there roles for intraductal US and saline solution irrigation in ensuring complete clearance of common bile duct stones?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21198919" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Lateral spread along the main pancreatic duct in branch-duct intraductal papillary-mucinous neoplasms of the pancreas: usefulness of intraductal ultrasonography for its evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9673562" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33728632" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24765600" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Endosonographic preoperative evaluation for tumors of the ampulla of vater using endoscopic ultrasonography and intraductal ultrasonography.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
